Jakob Lindberg joined Investor Growth Capital Europe (Stockholm) in the beginning of 2006 after working as a consultant for one year. Jakob focuses on investments in life sciences.
Prior to joining Investor Growth Capital Europe, Jakob worked at McKinsey & Company. and was the co-founder and CEO of Cellectricon AB, a Swedish company developing functional cell-based screening devices for drug discovery.
Jakob is a licensed Swedish physician with a M.D. degree from the Karolinska Institute and a B.A. in Finance from Stockholm University.